Integrated treatment of treatment-resistant depression – a case study of Ericksonian psychotherapy assisted by intravenous ketamine

The article presents a case study of a 22-year-old female patient suffering from severe, treatment-resistant depression who did not respond to standard pharmacological treatments and psychotherapy.An integrated, three-phase therapeutic model was implemented, combining Ericksonian psychotherapy with intravenous ketamine infusions.The treatment process included a preparatory phase, a series of 12 ketamine infusions, and a six-month integration therapy phase.In this approach, the altered state of consciousness induced by ketamine was utilized as a therapeutic trance, which facilitated bypassing the patient's rigid cognitive patterns and accessing her unconscious resources.The therapy resulted in a significant and lasting reduction in symptoms of depression and anxiety, confirmed by both quantitative and qualitative analysis.The author concludes that the synergy between a biological intervention (ketamine) and psychotherapy, based on preparation, a catalytic intervention, and integration, represents a promising, personalized method for treating severe mental disorders.

Authors

Publication Details

Journal
Psychiatria Spersonalizowana
Published
2025-01-01
DOI
https://doi.org/10.5114/psychs.2025.153854
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated treatment of treatment-resistant depression – a case study of Ericksonian psychotherapy assisted by intravenous ketamine

Szymon Niemiec
Psychiatria Spersonalizowana
Treatment of Major Depression
article

Integrated treatment of treatment-resistant depression – a case study of Ericksonian psychotherapy assisted by intravenous ketamine

Szymon Niemiec
article en

Abstract

The article presents a case study of a 22-year-old female patient suffering from severe, treatment-resistant depression who did not respond to standard pharmacological treatments and psychotherapy.An integrated, three-phase therapeutic model was implemented, combining Ericksonian psychotherapy with intravenous ketamine infusions.The treatment process included a preparatory phase, a series of 12 ketamine infusions, and a six-month integration therapy phase.In this approach, the altered state of consciousness induced by ketamine was utilized as a therapeutic trance, which facilitated bypassing the patient's rigid cognitive patterns and accessing her unconscious resources.The therapy resulted in a significant and lasting reduction in symptoms of depression and anxiety, confirmed by both quantitative and qualitative analysis.The author concludes that the synergy between a biological intervention (ketamine) and psychotherapy, based on preparation, a catalytic intervention, and integration, represents a promising, personalized method for treating severe mental disorders.

Psychiatria SpersonalizowanaVol. 4(1)
Openalex Percentile: Top 72%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.